Global Bone Cancer Drugs Market Insights and Trends
Bone cancer drugs are specialized pharmaceutical agents used in the treatment and management of bone cancer, a rare but serious condition that originates in or spreads to the bones. Bone cancer can be classified into primary bone cancers (such as osteosarcoma, chondrosarcoma, and Ewing sarcoma) that originate in the bone itself, and secondary or metastatic bone cancers, these occur when cancer from another area of the body, such as the breast, prostate, or lungs, spreads to the bones.